References
- Arinsoy, T., Akpolat, T., Ataman, M., Arik, N., Sungur, C., et al. 1993. Sudden hearing loss in a cyclosporin-treated renal transplantation patient. Nephron, 63, 116–117.
- Bayazit, Y.A., Balat, A., Pakir, H.I., Güler, E. & Kanlikama, M. 2005. Influence of the relapse and remission periods on hearing status in children with minimal change nephrotic syndrome. Rev Laryngol Otol Rhinol (Bord), 126, 171–173.
- Cole, E., Keown, P., Landsberg, D., Halloran, P., Shoker, A., et al. 1998. Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients: a report of the Canadian Neoral Renal Study Group. Transplantation, 65, 505–510.
- Di Leo, E., Coppola, F., Nettis, E., Vacca, A. & Quaranta, N. 2011. Late recovery with cyclosporine-A of an auto-immune sudden sensorineural hearing loss. Acta Otorhinolaryngol Ital, 31, 399–401.
- Elidan, J., Levi, H., Cohen, E. & BenEzra, D. 1991. Effect of cyclosporine A on the hearing loss in Behçet's disease. Ann Otol Rhinol Laryngol, 100, 464–468.
- Gulleroglu, K., Baskin, E., Aydin, E., Ozluoglu, L., Moray, G., et al. 2015. Hearing status in pediatric renal transplant recipients. Exp Clin Transplant, 13, 324–328.
- Hautefort, C., Loundon, N., Montchilova, M., Marlin, S., Garabedian, E.N., et al. 2009. Mycophenolate mofetil as a treatment of steroid dependent Cogan's syndrome in childhood. Int J Pediatr Otorhinolaryngol, 73, 1477–1479.
- Lasak, J.M., Sataloff, R.T., Hawkshaw, M., Carey, T.E., Lyons, K.M., et al. 2001. Autoimmune inner ear disease: steroid and cytotoxic drug therapy. Ear Nose Throat J, 80, 808–811.
- Marioni, G., Perin, N., Tregnaghi, A., Bellemo, B., Staffieri, A., et al. 2004. Progressive bilateral sensorineural hearing loss probably induced by chronic cyclosporin A treatment after renal transplantation for focal glomerulosclerosis. Acta Otolaryngol, 124, 603–607.
- Matsuoka, A.J. & Harris, J.P. 2013. Autoimmune inner ear disease: a retrospective review of forty-seven patients. E Audiol Neurootol, 18, 228–239.
- McClelland, L., Powell, R.J. & Birchall, J. 2005. Role of ciclosporin in steroid-responsive sudden sensorineural hearing loss. Acta Otolaryngol, 125, 1356–1360.
- Minami, S.B., Yamashita, D., Schacht, J. & Miller, J.M. 2004. Calcineurin activation contributes to noise-induced hearing loss. J Neurosci Res, 78, 383–392.
- Niaudet, P. & Boyer, O. 2004. Idiopathic Nephrotic Syndrome in children: Clinical aspects. In: Avner, E.D., Harmon, W.E., Niaudet, P. & Yoshikawa, N. (eds.) Pediatric Nephrology. 5th ed. Springer-Verlag Berlin Heidelberg; Springer, pp. 643–666.
- Orendorz-Fraczkowska, K., Medynska, A., Jablonka, A. & Gawron, W. 2008. Hearing organ function in children with nephrotic syndrome in the course of primary glomerulopathy. Otolaryngol Pol, 62, 182–187.
- Rifai, K., Kirchner, G.I., Bahr, M.J., Cantz, T., Rosenau, J., et al. 2006. A new side effect of immunosuppression: high incidence of hearing impairment after liver transplantation. Liver Transpl, 12, 411–415.
- Roeser, R.J., Buckley, K.A. & Stickney, G.S. 2000. Pure tone tests. In: Roeser RJ, Valente M, Hosford-Dunn H, editors. 1st ed. Audiology Diagnosis. New York: Thieme Medical Publishers, pp. 227–251.
- Saha, A., Gupta, V., Kapoor, K., Dubey, N.K., Lal, P., et al. 2013. Hearing status in children with frequently relapsing and steroid resistant nephrotic syndrome. Pediatr Nephrol, 28, 439–445.
- Saito, T., Zhang, Z.J., Tokuriki, M., Shibamori, Y., Yamamoto, T., et al. 2001. Cyclosporin A inhibits the extrusion pump function of p-glycoprotein in the inner ear of mice treated with vinblastine and doxorubicin. Brain Res, 901, 265–270.
- Uemaetomari, I., Tabuchi, K., Hoshino, T. & Hara, A. 2005. Protective effect of calcineurin inhibitors on acoustic injury of the cochlea. Hear Res, 209, 86–90.